Combating MDR Gram-negative infections: A real-world outlook

Multidrug resistance (MDR) has become a major problem for treating bacterial infections and is the greatest challenge to public health worldwide. Infections caused by multidrug-resistant gram-negative bacteria (MDR-GNB) have increased significantly in recent years worldwide. Epidemiological surveillance is a key for monitoring the mortality and morbidity due to MDR GNB infections. 1 To shed more light on this, Pfizer and Docplexus have organized an interactive LIVE webinar on 12th August, 2021 from 5.00 PM onwards .

Please join experts;   Dr. Anup Warrier and Dr. Rajesh Chawla   who will be sharing their insights on "Combating MDR Gram-negative infections: A real-world outlook." Agenda of this webinar is as follow: Stay tuned for the session! Reference:  1)Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, Heeg P, Ilschner C, Kramer A, Larson E, Merkens W.…